Given the pivotal role of PKCs in airway diseases, particularly asthma and COPD [25], we investigated their involvement in SiNPs-induced COX-2 expression in HTSMCs using the selective PKCα inhibitor, Gö6976. Here, PRKCA is linked to chronic obstructive pulmonary disease.